Tag: GNI Group

GNI Group to stop patient enrolment in F351 phase 2 liver fibrosis trial

pharmanewsdaily- October 2, 2018

Japanese biotech company GNI Group will end enrolment of new patients for a phase 2 liver fibrosis trial of its drug candidate F351 in China ... Read More